Global Circulating Tumor Cells (CTC) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023


Jan, 2019 | Report ID: 46789 | 118 | Pharmaceuticals and Healthcare

Circulating tumor cells are cells that have shed into the vasculature or lymphatics from a primary tumor and are carried around the body in the blood circulation.


Scope of the Report:

This report studies the Circulating Tumor Cells (CTC) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Circulating Tumor Cells (CTC) market by product type and applications/end industries.
Asia Pacific is expected to be the fastest growth region in circulating tumor cells market over the forecast period owing to the increasing incidences of cance.
The global Circulating Tumor Cells (CTC) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Circulating Tumor Cells (CTC).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.


Market Segment by Companies, this report covers

AdnaGen
Apocell
Biocep
Canopus Bioscience
Creatv Microtech
Ikonisys
IV Diagnostics
Miltenyi Biotech
Nanostring Technologies
Rarecells Diagnostics
Vitatex


Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)


Market Segment by Type, covers

Ex-Vivo Positive Selection
In-Vivo Positive Selection
Negative Selection
Microchips & Single Spiral Micro Channel


Market Segment by Applications, can be divided into

Tumorigenesis Research
Emt Biomarkers Development
Cancer Stem Cell Research
Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents



1 Circulating Tumor Cells (CTC) Market Overview

1.1 Product Overview and Scope of Circulating Tumor Cells (CTC)

1.2 Classification of Circulating Tumor Cells (CTC) by Types

1.2.1 Global Circulating Tumor Cells (CTC) Revenue Comparison by Types (2017-2023)

1.2.2 Global Circulating Tumor Cells (CTC) Revenue Market Share by Types in 2017

1.2.3 Ex-Vivo Positive Selection

1.2.4 In-Vivo Positive Selection

1.2.5 Negative Selection

1.2.6 Microchips & Single Spiral Micro Channel

1.3 Global Circulating Tumor Cells (CTC) Market by Application

1.3.1 Global Circulating Tumor Cells (CTC) Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Tumorigenesis Research

1.3.3 Emt Biomarkers Development

1.3.4 Cancer Stem Cell Research

1.3.5 Others

1.4 Global Circulating Tumor Cells (CTC) Market by Regions

1.4.1 Global Circulating Tumor Cells (CTC) Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Circulating Tumor Cells (CTC) Status and Prospect (2013-2023)

1.5 Global Market Size of Circulating Tumor Cells (CTC) (2013-2023)

2 Manufacturers Profiles

2.1 AdnaGen

2.1.1 Business Overview

2.1.2 Circulating Tumor Cells (CTC) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AdnaGen Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.2 Apocell

2.2.1 Business Overview

2.2.2 Circulating Tumor Cells (CTC) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Apocell Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.3 Biocep

2.3.1 Business Overview

2.3.2 Circulating Tumor Cells (CTC) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Biocep Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.4 Canopus Bioscience

2.4.1 Business Overview

2.4.2 Circulating Tumor Cells (CTC) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Canopus Bioscience Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.5 Creatv Microtech

2.5.1 Business Overview

2.5.2 Circulating Tumor Cells (CTC) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Creatv Microtech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.6 Ikonisys

2.6.1 Business Overview

2.6.2 Circulating Tumor Cells (CTC) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Ikonisys Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.7 IV Diagnostics

2.7.1 Business Overview

2.7.2 Circulating Tumor Cells (CTC) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 IV Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.8 Miltenyi Biotech

2.8.1 Business Overview

2.8.2 Circulating Tumor Cells (CTC) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Miltenyi Biotech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.9 Nanostring Technologies

2.9.1 Business Overview

2.9.2 Circulating Tumor Cells (CTC) Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Nanostring Technologies Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.10 Rarecells Diagnostics

2.10.1 Business Overview

2.10.2 Circulating Tumor Cells (CTC) Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Rarecells Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

2.11 Vitatex

2.11.1 Business Overview

2.11.2 Circulating Tumor Cells (CTC) Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Vitatex Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

3 Global Circulating Tumor Cells (CTC) Market Competition, by Players

3.1 Global Circulating Tumor Cells (CTC) Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Circulating Tumor Cells (CTC) Players Market Share

3.2.2 Top 10 Circulating Tumor Cells (CTC) Players Market Share

3.3 Market Competition Trend

4 Global Circulating Tumor Cells (CTC) Market Size by Regions

4.1 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Regions

4.2 North America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

4.3 Europe Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

4.5 South America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

5 North America Circulating Tumor Cells (CTC) Revenue by Countries

5.1 North America Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

5.2 USA Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

5.3 Canada Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

5.4 Mexico Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

6 Europe Circulating Tumor Cells (CTC) Revenue by Countries

6.1 Europe Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

6.2 Germany Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

6.3 UK Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

6.4 France Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

6.5 Russia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

6.6 Italy Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Countries

7.1 Asia-Pacific Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

7.2 China Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

7.3 Japan Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

7.4 Korea Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

7.5 India Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

8 South America Circulating Tumor Cells (CTC) Revenue by Countries

8.1 South America Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

8.2 Brazil Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

8.3 Argentina Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

8.4 Colombia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Circulating Tumor Cells (CTC) by Countries

9.1 Middle East and Africa Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

9.2 Saudi Arabia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

9.3 UAE Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

9.4 Egypt Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

9.5 Nigeria Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

9.6 South Africa Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

10 Global Circulating Tumor Cells (CTC) Market Segment by Type

10.1 Global Circulating Tumor Cells (CTC) Revenue and Market Share by Type (2013-2018)

10.2 Global Circulating Tumor Cells (CTC) Market Forecast by Type (2018-2023)

10.3 Ex-Vivo Positive Selection Revenue Growth Rate (2013-2023)

10.4 In-Vivo Positive Selection Revenue Growth Rate (2013-2023)

10.5 Negative Selection Revenue Growth Rate (2013-2023)

10.6 Microchips & Single Spiral Micro Channel Revenue Growth Rate (2013-2023)

11 Global Circulating Tumor Cells (CTC) Market Segment by Application

11.1 Global Circulating Tumor Cells (CTC) Revenue Market Share by Application (2013-2018)

11.2 Circulating Tumor Cells (CTC) Market Forecast by Application (2018-2023)

11.3 Tumorigenesis Research Revenue Growth (2013-2018)

11.4 Emt Biomarkers Development Revenue Growth (2013-2018)

11.5 Cancer Stem Cell Research Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Circulating Tumor Cells (CTC) Market Size Forecast (2018-2023)

12.1 Global Circulating Tumor Cells (CTC) Market Size Forecast (2018-2023)

12.2 Global Circulating Tumor Cells (CTC) Market Forecast by Regions (2018-2023)

12.3 North America Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

12.4 Europe Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

12.6 South America Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Circulating Tumor Cells (CTC) Picture

Table Product Specifications of Circulating Tumor Cells (CTC)

Table Global Circulating Tumor Cells (CTC) and Revenue (Million USD) Market Split by Product Type

Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Types in 2017

Figure Ex-Vivo Positive Selection Picture

Figure In-Vivo Positive Selection Picture

Figure Negative Selection Picture

Figure Microchips & Single Spiral Micro Channel Picture

Table Global Circulating Tumor Cells (CTC) Revenue (Million USD) by Application (2013-2023)

Figure Circulating Tumor Cells (CTC) Revenue Market Share by Applications in 2017

Figure Tumorigenesis Research Picture

Figure Emt Biomarkers Development Picture

Figure Cancer Stem Cell Research Picture

Figure Others Picture

Table Global Market Circulating Tumor Cells (CTC) Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (2013-2023)

Table AdnaGen Basic Information, Manufacturing Base and Competitors

Table AdnaGen Circulating Tumor Cells (CTC) Type and Applications

Table AdnaGen Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Apocell Basic Information, Manufacturing Base and Competitors

Table Apocell Circulating Tumor Cells (CTC) Type and Applications

Table Apocell Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Biocep Basic Information, Manufacturing Base and Competitors

Table Biocep Circulating Tumor Cells (CTC) Type and Applications

Table Biocep Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Canopus Bioscience Basic Information, Manufacturing Base and Competitors

Table Canopus Bioscience Circulating Tumor Cells (CTC) Type and Applications

Table Canopus Bioscience Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Creatv Microtech Basic Information, Manufacturing Base and Competitors

Table Creatv Microtech Circulating Tumor Cells (CTC) Type and Applications

Table Creatv Microtech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Ikonisys Basic Information, Manufacturing Base and Competitors

Table Ikonisys Circulating Tumor Cells (CTC) Type and Applications

Table Ikonisys Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table IV Diagnostics Basic Information, Manufacturing Base and Competitors

Table IV Diagnostics Circulating Tumor Cells (CTC) Type and Applications

Table IV Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Miltenyi Biotech Basic Information, Manufacturing Base and Competitors

Table Miltenyi Biotech Circulating Tumor Cells (CTC) Type and Applications

Table Miltenyi Biotech Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Nanostring Technologies Basic Information, Manufacturing Base and Competitors

Table Nanostring Technologies Circulating Tumor Cells (CTC) Type and Applications

Table Nanostring Technologies Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Rarecells Diagnostics Basic Information, Manufacturing Base and Competitors

Table Rarecells Diagnostics Circulating Tumor Cells (CTC) Type and Applications

Table Rarecells Diagnostics Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Vitatex Basic Information, Manufacturing Base and Competitors

Table Vitatex Circulating Tumor Cells (CTC) Type and Applications

Table Vitatex Circulating Tumor Cells (CTC) Revenue, Gross Margin and Market Share (2016-2017)

Table Global Circulating Tumor Cells (CTC) Revenue (Million USD) by Players (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue Share by Players (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Share by Players in 2016

Figure Global Circulating Tumor Cells (CTC) Revenue Share by Players in 2017

Figure Global Top 5 Players Circulating Tumor Cells (CTC) Revenue Market Share in 2017

Figure Global Top 10 Players Circulating Tumor Cells (CTC) Revenue Market Share in 2017

Figure Global Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue (Million USD) by Regions (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue Market Share by Regions (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Regions (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Market Share by Regions in 2017

Figure North America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Europe Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure South America Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Table North America Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

Table North America Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure North America Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure North America Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2017

Figure USA Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Canada Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Mexico Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Table Europe Circulating Tumor Cells (CTC) Revenue (Million USD) by Countries (2013-2018)

Figure Europe Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure Europe Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2017

Figure Germany Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure UK Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure France Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Russia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Italy Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Circulating Tumor Cells (CTC) Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2017

Figure China Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Japan Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Korea Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure India Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Table South America Circulating Tumor Cells (CTC) Revenue by Countries (2013-2018)

Table South America Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure South America Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure South America Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2017

Figure Brazil Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Argentina Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Colombia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Circulating Tumor Cells (CTC) Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure UAE Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Egypt Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure Nigeria Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Figure South Africa Circulating Tumor Cells (CTC) Revenue and Growth Rate (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue (Million USD) by Type (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue Share by Type (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Share by Type (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Share by Type in 2017

Table Global Circulating Tumor Cells (CTC) Revenue Forecast by Type (2018-2023)

Figure Global Circulating Tumor Cells (CTC) Market Share Forecast by Type (2018-2023)

Figure Global Ex-Vivo Positive Selection Revenue Growth Rate (2013-2018)

Figure Global In-Vivo Positive Selection Revenue Growth Rate (2013-2018)

Figure Global Negative Selection Revenue Growth Rate (2013-2018)

Figure Global Microchips & Single Spiral Micro Channel Revenue Growth Rate (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue by Application (2013-2018)

Table Global Circulating Tumor Cells (CTC) Revenue Share by Application (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Share by Application (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue Share by Application in 2017

Table Global Circulating Tumor Cells (CTC) Revenue Forecast by Application (2018-2023)

Figure Global Circulating Tumor Cells (CTC) Market Share Forecast by Application (2018-2023)

Figure Global Tumorigenesis Research Revenue Growth Rate (2013-2018)

Figure Global Emt Biomarkers Development Revenue Growth Rate (2013-2018)

Figure Global Cancer Stem Cell Research Revenue Growth Rate (2013-2018)

Figure Global Others Revenue Growth Rate (2013-2018)

Figure Global Circulating Tumor Cells (CTC) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Circulating Tumor Cells (CTC) Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Circulating Tumor Cells (CTC) Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

Figure Europe Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

Figure South America Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Circulating Tumor Cells (CTC) Revenue Market Forecast (2018-2023)

Sample Request is not available